176 related articles for article (PubMed ID: 32647340)
1. Increased S1P induces S1PR2 internalization to blunt the sensitivity of colorectal cancer to 5-fluorouracil via promoting intracellular uracil generation.
Zhang YH; Cui SX; Wan SB; Wu SH; Qu XJ
Acta Pharmacol Sin; 2021 Mar; 42(3):460-469. PubMed ID: 32647340
[TBL] [Abstract][Full Text] [Related]
2. S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer.
Zhang YH; Luo DD; Wan SB; Qu XJ
Pharmacol Res; 2020 May; 155():104717. PubMed ID: 32088343
[TBL] [Abstract][Full Text] [Related]
3. Novel 5-fluorouracil sensitizers for colorectal cancer therapy: Design and synthesis of S1P receptor 2 (S1PR2) antagonists.
Luo D; Guo Z; Zhao X; Wu L; Liu X; Zhang Y; Zhang Y; Deng Z; Qu X; Cui S; Wan S
Eur J Med Chem; 2022 Jan; 227():113923. PubMed ID: 34688013
[TBL] [Abstract][Full Text] [Related]
4. ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield.
Ou J; Peng Y; Yang W; Zhang Y; Hao J; Li F; Chen Y; Zhao Y; Xie X; Wu S; Zha L; Luo X; Xie G; Wang L; Sun W; Zhou Q; Li J; Liang H
Nat Commun; 2019 Mar; 10(1):1078. PubMed ID: 30842415
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer.
Luo D; Zhang Y; Yang S; Tian X; Lv Y; Guo Z; Liu X; Han G; Liu S; Wang W; Cui S; Qu X; Wan S
Eur J Med Chem; 2021 Dec; 225():113775. PubMed ID: 34411894
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of JTE-013 derivatives as novel potent S1PR2 antagonists for recovering the sensitivity of colorectal cancer to 5-fluorouracil.
Guo Z; Zhang S; Liu X; Zhao G; Zhang Y; Luo D; Zhao X; Xu X; Qu X; Li L; Wan S; Cui S
Bioorg Chem; 2023 Feb; 131():106318. PubMed ID: 36527992
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil recruitment mediated by sphingosine 1-phosphate (S1P)/S1P receptors during chronic liver injury.
Zhao X; Yang L; Chang N; Hou L; Zhou X; Dong C; Liu F; Yang L; Li L
Cell Immunol; 2021 Jan; 359():104243. PubMed ID: 33197723
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate/S1PR2-mediated signaling triggers Smad1/5/8 phosphorylation and thereby induces Runx2 expression in osteoblasts.
Higashi K; Matsuzaki E; Hashimoto Y; Takahashi-Yanaga F; Takano A; Anan H; Hirata M; Nishimura F
Bone; 2016 Dec; 93():1-11. PubMed ID: 27612439
[TBL] [Abstract][Full Text] [Related]
9. The Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis in Intestinal Epithelial Cells Regulates Intestinal Barrier Function During Intestinal Epithelial Cells-CD4+T-Cell Interactions.
Chen T; Lin R; Jin S; Chen R; Xue H; Ye H; Huang Z
Cell Physiol Biochem; 2018; 48(3):1188-1200. PubMed ID: 30045015
[TBL] [Abstract][Full Text] [Related]
10. Alteration of sphingosine-1-phosphate with aging induces contractile dysfunction of colonic smooth muscle cells via Ca
Shen X; Zhang L; Jiang L; Xiong W; Tang Y; Lin L; Yu T
Neurogastroenterol Motil; 2021 May; 33(5):e14052. PubMed ID: 33452855
[TBL] [Abstract][Full Text] [Related]
11. The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses.
Oskeritzian CA; Hait NC; Wedman P; Chumanevich A; Kolawole EM; Price MM; Falanga YT; Harikumar KB; Ryan JJ; Milstien S; Sabbadini R; Spiegel S
J Allergy Clin Immunol; 2015 Apr; 135(4):1008-1018.e1. PubMed ID: 25512083
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1 phosphate promotes intestinal epithelial cell proliferation via S1PR2.
Chen T; Huang Z; Liu R; Yang J; Hylemon PB; Zhou H
Front Biosci (Landmark Ed); 2017 Jan; 22(4):596-608. PubMed ID: 27814635
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia-Triggered Sphingosine-1-Phosphate and Sphingosine-1-Phosphate Receptor 3 Signaling Worsens Liver Ischemia/Reperfusion Injury by Regulating M1/M2 Polarization.
Hu Y; Yang C; Shen G; Yang S; Cheng X; Cheng F; Rao J; Wang X
Liver Transpl; 2019 Jul; 25(7):1074-1090. PubMed ID: 30972941
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 inflammasome priming and activation in cholestatic liver injury via the sphingosine 1-phosphate/S1P receptor 2/Gα
Hou L; Zhang Z; Yang L; Chang N; Zhao X; Zhou X; Yang L; Li L
J Mol Med (Berl); 2021 Feb; 99(2):273-288. PubMed ID: 33388881
[TBL] [Abstract][Full Text] [Related]
15. Targeting the SPHK1/S1P/S1PR2 axis ameliorates GH-secreted pituitary adenoma progression.
Sun H; Hu B; Wu C; Jiang T
Eur J Clin Invest; 2024 Mar; 54(3):e14117. PubMed ID: 37888843
[TBL] [Abstract][Full Text] [Related]
16. Association between sphingosine-1-phosphate-induced signal transduction via mitogen-activated protein kinase pathways and keloid formation.
Jung SH; Song YK; Chung H; Ko HM; Lee SH; Jo DI; Kim B; Lee DH; Kim SH
Arch Dermatol Res; 2019 Nov; 311(9):711-719. PubMed ID: 31385019
[TBL] [Abstract][Full Text] [Related]
17. Differential activation of receptors and signal pathways upon stimulation by different doses of sphingosine-1-phosphate in endothelial cells.
Li Q; Chen B; Zeng C; Fan A; Yuan Y; Guo X; Huang X; Huang Q
Exp Physiol; 2015 Jan; 100(1):95-107. PubMed ID: 25557733
[TBL] [Abstract][Full Text] [Related]
18. Expression of sphingosine-1-phosphate receptor 2 is correlated with migration and invasion of human colon cancer cells: A preliminary clinical study.
Yan J; Chen Y; Wu Q; Shao L; Zhou X
Oncol Lett; 2022 Jul; 24(1):241. PubMed ID: 35720474
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation.
Orr Gandy KA; Adada M; Canals D; Carroll B; Roddy P; Hannun YA; Obeid LM
FASEB J; 2013 Aug; 27(8):3155-66. PubMed ID: 23629860
[TBL] [Abstract][Full Text] [Related]
20. The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.
Wang Y; Aoki H; Yang J; Peng K; Liu R; Li X; Qiang X; Sun L; Gurley EC; Lai G; Zhang L; Liang G; Nagahashi M; Takabe K; Pandak WM; Hylemon PB; Zhou H
Hepatology; 2017 Jun; 65(6):2005-2018. PubMed ID: 28120434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
